Agenda
Thursday, October 17, 2024
Session 1: Histone Modifications and Chromatin Structure
Chair: David Clark, Ph.D., National Institute of Child Health and Human Development, NIH
Brian Strahl, Ph.D., University of North Carolina at Chapel Hill
Shelley Berger, Ph.D., University of Pennsylvania
Ali Shilatifard, Ph.D., Northwestern University
Tom Muir, Ph.D., Princeton University
Session 2: Chromatin Remodeling and Histone Dynamics
Chair: Alexander Kelly.Ph.D., Center for Cancer Research, NCI
Carl Wu, Ph.D., Johns Hopkins University
Keji Zhao, Ph.D., National Heart, Lung, and Blood Institute, NIH
Genevieve Almouzni, Ph.D., Curie Institute
Steve Henikoff, Ph.D., Fred Hutch Cancer Center
Session 3: Chromatin Modifications and Gene Expression
Chair: Eros Lazzerini Denchi, Ph.D., Center for Cancer Research, NCI
Emily Bernstein, Ph.D., Icahn School of Medicine at Mount Sinai
Asifa Akhtar, Ph.D., Max Planck Institute
Yi Zhang, Ph.D., Harvard Medical School
Payel Sen, Ph.D., National Institute of Aging, NIH
Friday, October 18, 2024
Session 4: Chromatin Organization and Genome Stability
Chair: Elissa Lei, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases, NIH
Iestyn Whitehouse, Ph.D., Memorial Sloan Kettering Cancer Center
Mirit I. Aladjem, Ph.D., Center for Cancer Research, NCI
Todd Macfarlan, Ph.D., National Institute of Child Health and Human Development, NIH
Bing Ren, Ph.D., University of California, San Diego
Session 5: Histone Modifications and Development
Chair: Yamini Dalal, Ph.D. Center for Cancer Research, NCI
Joanna Wysocka, Ph.D., Stanford University
Eva Nogales, Ph.D., University of California, Berkeley
Kenneth Zaret, Ph.D., University of Pennsylvania
Yawen Bai, Ph.D., Center for Cancer Research, NCI
Session 6: Histone Modifications and Gene Silencing
Chair: Alan Hinnebusch, Ph.D., National Institute of Child Health and Human Development, NIH
Peter Lewis, Ph.D., University of Wisconsin, Madison
Kathrin Plath, Ph.D., University of California, Los Angeles
Thomas Jenuwein, Ph.D., Max Planck Institute
Shiv Grewal, Ph.D., Center for Cancer Research, NCI